Last week, CMS issued a memo to states alerting them of the likelihood that their Medicaid programs will have to fill prescription drug requests for voriconazole, the antifungal drug CDC has recommended to treat infection caused by the New England Compounding Center's contaminated steroid injections. "At this time, CMS expects states to be prepared for new Medicaid prescription requests for voriconazole as part of the regimen specified in the CDC interim treatment guidance .... Given the severity of this situation, we also expect states to expedite all coverage determination requests for this medication, and other appropriate antifungal medications, due to the potentially life-threatening consequences of a delay in therapy for those patients with CNS and/or parameningeal infections and septic arthritis."